CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Project Information

PREVENTABLE

Grant agreement ID: 101095483

DOI

10.3030/101095483

EC signature date 2 December 2022

Start date 1 January 2023

End date 30 June 2026

Funded under

• Health

Total cost

€ 4 686 000,00

EU contribution

€ 4 642 249,75

Coordinated by

I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO
Portugal

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (3)

Dissemination & Exploitation Plan, including communication activities and RTRS-specific content 2

Dissemination & Exploitation Plan, including communication activities and RTRS-specificcontent 2

Dissemination & Exploitation Plan, including communication activities and RTRS-specific content 1

Dissemination & Exploitation Plan, including communication activities and RTRS-specificcontent 1

Project website

Other (1)

Cost-benefit model care pathways of RTRS and per RTRS 1

Publications

Other (1)

PREVENTABLE: an European study on cost-effectiveness of prevention in rare tumour risk syndromes

Author(s): Sara B. Pereira; Liliana Sousa; Ricardo Amorim; Luzia Garrido; Bárbara Peleteiro; Stefan Aretz; Judith Balmaña; Juan Brunet; Claude Houdayer; Svetlana Bajalica-Lagercrantz; Igor Lopes; Judite Gonçalves; Nuno Teixeira Marcos; Marta M. Marques; Céu Mateus;
Publisher: Zenodo
DOI: 10.5281/ZENODO.14893719

Peer reviewed articles (1)

Hereditary diffuse gastric cancer spectrum associated with germline <i>CTNNA1</i> loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls

Author(s): Silvana Lobo, Alexandre Dias, Ana Maria Pedro, Marta Ferreira, André Pinto-Oliveira, Celina São José, Jennifer Herrera-Mullar, Nádia Pinto, Chrystelle Colas, Robert Hüneburg, Jacob Nattermann, Lise Boussemart, Liselotte P van Hest, Leticia Moreira, Carolyn Horton, Dana Farengo Clark, Sigrid Tinschert, Lisa Golmard, Isabel Spier, Adriá López-Fernández, Daniela Oliveira, Magali SVRCEK, Pierre Bourgoin, Florence Coulet, Hélène Delhomelle, Jeremy Davis, Birthe Zäncker, Conxi Lazaro, Joana Guerra, Maria L Almeida, Sergio Carrera, Ana Patiño, Paul Gundlach, Monika Laszkowska, Vivian E Strong, Manuel R Teixeira, Intan Schrader, Verena Steinke-Lange, Irene Gullo, Sérgio Sousa, Manuela Batista, Stefan Aretz, Judith Balmaña, Melyssa Aronson, Augusto Perazzolo Antoniazzi, Edenir I Palmero, Paul Mansfield, Lizet E van der Kolk, Annemieke Cats, Jolanda M van Dieren, Sergi Castellví-Bel, Bryson Katona, Rachid Karam, Paulo S Pereira, Patrick R Benusiglio, Carla Oliveira
Published in: Gut, 2025, ISSN 0017-5749
Publisher: BMJ
DOI: 10.1136/GUTJNL-2024-334601